These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36752370)

  • 21. Noncalcified Ductal Carcinoma In Situ (DCIS): Rate and Predictors of Upgrade to Invasive Carcinoma.
    Lamb LR; Kim G; Oseni TO; Bahl M
    Acad Radiol; 2021 Mar; 28(3):e71-e76. PubMed ID: 32222328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benign breast papillomas without atypia diagnosed with core needle biopsy: Outcome of surgical excision and imaging follow-up.
    Polat DS; Knippa EE; Ganti R; Seiler SJ; Goudreau SH
    Eur J Radiol; 2020 Oct; 131():109237. PubMed ID: 32905954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of Omitting Sentinel Lymph Node Biopsy in an Under-screened Cohort of Breast Cancer Patients With a Premastectomy Diagnosis of Ductal Carcinoma In Situ.
    Pang J; Yan Z; Tan QT; Allen JC; Wang M; Lim GH
    Clin Breast Cancer; 2024 Jun; 24(4):363-367. PubMed ID: 38458843
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.
    Schulz S; Sinn P; Golatta M; Rauch G; Junkermann H; Schuetz F; Sohn C; Heil J
    Breast; 2013 Aug; 22(4):537-42. PubMed ID: 23237921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
    Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
    Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rate of postoperative upstaging of ductal carcinoma in situ when prioritizing ultrasound evaluation of mammography-detected lesions: a single-center retrospective cohort study.
    Hsieh YC; Lo C; Lee YH; Chien N; Lu TP; Tsai LW; Wang MY; Kuo WH; Chang YC; Huang CS
    World J Surg Oncol; 2023 Feb; 21(1):48. PubMed ID: 36804000
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
    Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
    Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrafast MRI and T1 and T2 Radiomics for Predicting Invasive Components in Ductal Carcinoma in Situ Diagnosed With Percutaneous Needle Biopsy.
    Kim MY; Yoen H; Ji H; Park SJ; Kim SM; Han W; Cho N
    Korean J Radiol; 2023 Dec; 24(12):1190-1199. PubMed ID: 38016679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is Sentinel Lymph Node Biopsy Necessary for Ductal Carcinoma In Situ Patients Undergoing Mastectomy?
    Miller-Ocuin JL; Howard-McNatt M; Levine EA; Chiba A
    Am Surg; 2020 Aug; 86(8):955-957. PubMed ID: 32862671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of preoperative magnetic resonance imaging on surgical treatment and outcomes for ductal carcinoma in situ.
    Itakura K; Lessing J; Sakata T; Heinzerling A; Vriens E; Wisner D; Alvarado M; Esserman L; Ewing C; Hylton N; Hwang ES
    Clin Breast Cancer; 2011 Mar; 11(1):33-8. PubMed ID: 21421520
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
    Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
    Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of Underestimation Using Contrast-Enhanced Spectral Mammography in Patients Diagnosed as Ductal Carcinoma In Situ on Preoperative Core Biopsy.
    Shin HJ; Choi WJ; Park SY; Ahn SH; Son BH; Chung IY; Lee JW; Ko BS; Kim JS; Chae EY; Cha JH; Kim HH
    Clin Breast Cancer; 2022 Apr; 22(3):e374-e386. PubMed ID: 34776365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
    Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
    Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of breast MRI in women eligible for breast conservation surgery and intra-operative radiation therapy.
    Paudel N; Bethke KP; Wang LC; Strauss JB; Hayes JP; Donnelly ED
    Surg Oncol; 2018 Mar; 27(1):95-99. PubMed ID: 29549911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative Breast MRI for Newly Diagnosed Ductal Carcinoma in Situ: Imaging Features and Performance in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
    Chou SS; Romanoff J; Lehman CD; Khan SA; Carlos R; Badve SS; Xiao J; Corsetti RL; Javid SH; Spell DW; Han LK; Sabol JL; Bumberry JR; Gareen IF; Snyder BS; Gatsonis C; Wagner LI; Wolff AC; Miller KD; Sparano JA; Comstock CE; Rahbar H
    Radiology; 2021 Oct; 301(1):66-77. PubMed ID: 34342501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI.
    Amitai Y; Menes TS; Scaranelo A; Fleming R; Kulkarni S; Ghai S; Wey L; Mulligan AM; Mrkonjic M; Freitas VAR
    Breast Cancer Res Treat; 2021 Nov; 190(2):317-327. PubMed ID: 34476644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node positivity in patients undergoing mastectomies for ductal carcinoma in situ (DCIS).
    Price A; Schnabel F; Chun J; Kaplowitz E; Goodgal J; Guth A; Axelrod D; Shapiro R; Mema E; Moy L; Darvishian F; Roses D
    Breast J; 2020 May; 26(5):931-936. PubMed ID: 31957944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
    Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
    Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrafast dynamic contrast-enhanced breast MRI may generate prognostic imaging markers of breast cancer.
    Onishi N; Sadinski M; Hughes MC; Ko ES; Gibbs P; Gallagher KM; Fung MM; Hunt TJ; Martinez DF; Shukla-Dave A; Morris EA; Sutton EJ
    Breast Cancer Res; 2020 May; 22(1):58. PubMed ID: 32466799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Upgrade Rate of Ductal Carcinoma In Situ to Invasive Carcinoma and the Clinicopathological Factors Predicting the Upgrade Following a Mastectomy: A Retrospective Study.
    Al-Ishaq Z; Hajiesmaeili H; Rahman E; Khosla M; Sircar T
    Cureus; 2023 Mar; 15(3):e35735. PubMed ID: 37016659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.